endogene.bio, a biotech company focused on biomarker development in female health, has won BPI’s Innov’up, with €1.5 million in funding. The Innov’up program, administered by Bpifrance, provides financial assistance and strategic support to businesses with high potential for innovation and growth. It aims to accelerate the development of groundbreaking projects across various sectors.

This funding will support the next phase of development for the company's diagnostic solution for endometriosis. The award is an important milestone in endogene.bio's efforts to improve women's health through innovative diagnostic tools.

\